Inspirna Inc
Inspirna, Inc. is a clinical-stage biopharmaceutical company based in New York, NY, dedicated to developing innovative cancer therapeutics. Utilizing their proprietary RNA-DRIVEr platform, they identify previously unknown drivers of metastasis in common cancers, aiming to convert cancer into a manageable, chronic condition. With a focus on small molecules and biologics, Inspirna's pipeline includes first-in-class oral medications such as ompenaclid RGX-202 for RAS mutant colorectal cancer and abequolixron RGX-104 for non-small cell lung cancer and endometrial cancer.
By providing practical treatment options that prolong survival without compromising patients' quality of life, Inspirna strives to make a significant impact in areas of high unmet need. Their commitment to clinical validation and scientific discovery positions them as a leading player in the field of cancer research and development.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
